E2F transcription factors as multimodal biomarkers for pan-cancer management

Abstract Supplementary Information: The online version contains supplementary material available at 10.1038/s41598-025-31042-w. Article type: Research Article Keywords: Pan-cancer, E2F family, Prognosis, Immunotherapy response, Multi-omics, Immunotherapy, Cancer genomics, Gene expression, Gene regulation Authors: Shaobo Yang, Kai Li, Yong Suo, Zhe Zhang, Houyuan Chen, Yuda Lin, Chong Fu, Yunkai Qie, Chong Shen, Hailong Hu Affiliations: https://ror.org/03rc99w60grid.412648.d0000 0004 1798 6160Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, No. 23, Pingjiang Road, Tianjin, 300211 China; https://ror.org/03rc99w60grid.412648.d0000 0004 1798